SPONSOR
Northside Hospital, Inc.
Total Trials
2
Recruiting
2
Phases
Phase 2
Northside Hospital, Inc. is a clinical research sponsor with 2 registered studies on ClinicalTrials.gov, of which 2 are actively recruiting participants. Research covers conditions including Chronic Graft Versus Host Disease, Severe Aplastic Anemia.
The trial portfolio spans Phase 2 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — Northside Hospital, Inc.
How many clinical trials has Northside Hospital, Inc. sponsored?
ClinicalMetric currently tracks 2 clinical trials sponsored by Northside Hospital, Inc., of which 2 are actively recruiting participants. These trials cover conditions including Chronic Graft Versus Host Disease, Severe Aplastic Anemia. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Northside Hospital, Inc. research focus on?
Northside Hospital, Inc. clinical trials span Chronic Graft Versus Host Disease, Severe Aplastic Anemia. The research pipeline includes Phase 2 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a Northside Hospital, Inc. clinical trial?
To participate in a Northside Hospital, Inc. trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Northside Hospital, Inc. trials with current recruitment status updated daily.
Clinical Trials by Northside Hospital, Inc.
NCT06046248 Phase 2
Recruiting
Belumosudil and Rituximab for Primary Treatment of Chronic Graft-Versus-Host-Disease
Chronic Graft Versus Host Disease
NCT02828592 Phase 2
Recruiting
Haploidentical Bone Marrow Transplant With Post-Transplant Cyclophosphamide for Patients With Severe Aplastic Anemia
Severe Aplastic Anemia
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology